Wednesday, November 12, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

July 2019

Anna by Anna
15 May 2020
in 2019 Digital Magazines
0
Previous Post

June 2019

Next Post

August 2019

Next Post

August 2019

Minister for Health launches Ireland’s First National Endometriosis Framework

Minister for Health launches Ireland’s First National Endometriosis Framework

20 October 2025
Transforming Pharmacy

Transforming Pharmacy

15 October 2025
Menopause and the Role of the Pharmacist

Menopause and the Role of the Pharmacist

15 October 2025

RECOMMENDED NEWS

PSI – The Pharmacy Regulator announces nomination process now open for registered pharmacist appointments on the PSI Council

PSI – The Pharmacy Regulator announces nomination process now open for registered pharmacist appointments on the PSI Council

3 years ago
GSK plc has announced positive data from the ZOSTER-049 long-term follow-up phase III trial which followed participants for up to approximately 11 years following initial vaccination with Shingrix (Recombinant Zoster Vaccine or RZV). The final trial data demonstrate that RZV maintains efficacy against shingles for more than a decade in adults over 50. The data presented at the European Congress of Clinical Microbiology and Infectious Diseases (ESCMID) in Barcelona, Spain (27–30 April 2024) is based on the ZOSTER-049 study.1

New long-term data show Shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a decade

2 years ago
RCSI researchers discover new way to halt excessive inflammation

RCSI researchers discover new way to halt excessive inflammation

5 years ago
Proceive

Introducing Proceive® Every Mum: Targeted Support for Busy Mothers

2 years ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN